Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »
Reset 

The pharmaceutical contract manufacturing (CMO) market is expected to register a CAGR of over 7.75% during the forecast period 2019

NEW YORK, June 21, 2019 /PRNewswire/ -- Market Overview
The pharmaceutical contract manufacturing (CMO) market is expected to register a CAGR of over 7.75% during the forecast period 2019 - 2024. With the growing demand for generic medicines and biologics, the capital-intensive nature... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2019

The global medical scheduling software market is expected to reach US$ 789.56 Mn in 2027 from US$ 267.83 Mn in 2018

NEW YORK, June 21, 2019 /PRNewswire/ -- The global medical scheduling software market is expected to reach US$ 789.56 Mn in 2027 from US$ 267.83 Mn in 2018. The medical scheduling software market is estimated to grow with a CAGR of 13.0% from 2019-2027.



Read the full report:... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2019

RTR Urology, A 21st Century Oncology Practice, Offers Innovative Technology For Diagnosing And Treating Bladder Cancer

VENICE, Fla., June 21, 2019 /PRNewswire/ -- RTR Urology, a Division of 21(st) Century Oncology, the largest integrated cancer care network in America, is now offering its patients state-of-the-art treatment using "blue light cystoscopy," an innovative technology that allows doctors to more accurately... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2019
Related companies:  21st Century Scientific, Inc. | 21st Century Oncology, Inc. | 21st Century Biochemicals, Inc.

Portable X-Ray Devices Global Market Opportunities And Strategies To 2022

NEW YORK, June 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Jun 2019

Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Calithera Biosciences, Inc.

Avinger to Effect One-for-Ten Reverse Stock Split

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Avinger, Inc.

Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Kura Oncology, Inc.

AMAG Pharmaceuticals Announces FDA Approval of Vyleesi™ (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  AMAG Pharmaceuticals, Inc.

Kalytera Announces Grant of Stock Options to Directors

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Kalytera Therapeutics, Inc. | KALYTERA THERAPEUTICS

Corinth MedTech raises $12 Million in Series D funding led by ShangBay Capital

CUPERTINO, Calif., June 21, 2019 /PRNewswire/ -- Corinth MedTech, a urology healthcare company and the developer of the Veloxion System, for the treatment of BPH (Benign Prostatic Hyperplasia) and TURBT (Transurethral Resection of Bladder Tumor), today announced that it has completed a $12 million... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  ShangBay Capital LLC

$1.44 Bn Lancets Market, 2024 - Ease of Use and Simplicity have Driven Demand for Push-Button Lancets

DUBLIN, June 21, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

ELECTROCORE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In electroCore, Inc. To Contact The Firm

NEW YORK, June 21, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against electroCore, Inc. ("electroCore" or the "Company") (NASDAQ: ECOR).

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  electroCore LLC

Lab Automation in Bioanalysis Markets, 2024 - Rising Demand for Personalized Medicines & Technological Innovations Resulting in Improved Solutions

DUBLIN, June 21, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

China Pharmaceutical Distribution Industry Report, 2019-2025

NEW YORK, June 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019

Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

NEW YORK, June 21, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019

FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women

SILVER SPRING, Md., June 21, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

Read more ››
By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  U.S. Food and Drug Administration

FDA Approves New Drug Application for Vyleesi(TM) (bremelanotide injection)

CRANBURY, N.J., June 21, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval of AMAG Pharmaceuticals, Inc.'s New Drug Application (NDA) for Vyleesi(TM) (bremelanotide injection), a... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019
Related companies:  Palatin Technologies, Inc.

Acreage Obtains Final Order for Plan of Arrangement with Canopy Growth and Confirms Record Date for Acreage Shareholders Entitled to Receive the Option Premium

SMITHS FALLS, ON and NEW YORK, June 21, 2019 /CNW/ - Acreage Holdings, Inc. ("Acreage") (CSE:ACGR.U) (OTC: ACRGF) (FSE: 0ZV) and Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) (together, the "Companies") are pleased to announce that Acreage has... Read more ››

By: PR Newswire Association LLC. - 21 Jun 2019

Nabriva Therapeutics to Present Data at ASM Microbe Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin) for injection to Treat Complicated Urinary Tract Infections (cUTIs)

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Nabriva Therapeutics plc

Applied Therapeutics Reports First Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 21 Jun 2019
Related companies:  Applied Therapeutics Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »
to the top ↑